Literature DB >> 21733989

National decision-making on adopting new vaccines: a systematic review.

H E D Burchett1, S Mounier-Jack, U K Griffiths, A J Mills.   

Abstract

In recent years numerous new vaccines have been developed, offering potential reductions in the morbidity and mortality caused by a range of diseases. This has led to increased interest in decision-making about the adoption of new vaccines into national immunization programmes. This paper aims to systematically review the literature on national decision-making around the adoption of new vaccines. A thematic framework was developed inductively through analysis of the vaccine adoption decision-making frameworks included in the review. This thematic framework was then applied to the remaining studies included in the review. In total, 85 articles were included in the review: 39 articles describing examples of vaccine adoption decision-making, 26 presenting vaccine decision-making frameworks, 21 empirical articles of decision-making relating to vaccine adoption and 19 theoretical essays. An analysis of vaccine adoption decision-making frameworks identified nine broad categories of criteria: the importance of the health problem; vaccine characteristics; immunization programme considerations; acceptability; accessibility, equity and ethics; financial/economic issues; impact; alternative interventions and the decision-making process. The quality of the empirical studies was varied. Although some of the issues included in the frameworks were similar to those considered in the studies, there were also some notable differences. On the whole, the frameworks were more comprehensive than the studies, including a greater range of criteria. The existing literature provides a good foundation for further research into vaccine adoption decision-making. The current review, in pulling together what is already known and by identifying strengths, weaknesses and gaps in the existing evidence base, aims to encourage a more focused and rigorous approach to the topic in future. This could help to identify the most appropriate ways to develop vaccine adoption decision-making, so as to improve decisions and, ultimately, health outcomes.

Mesh:

Substances:

Year:  2011        PMID: 21733989     DOI: 10.1093/heapol/czr049

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  24 in total

1.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

2.  Introduction of pentavalent vaccine in Indonesia: a policy analysis.

Authors:  Panji F Hadisoemarto; Michael R Reich; Marcia C Castro
Journal:  Health Policy Plan       Date:  2016-04-23       Impact factor: 3.344

3.  Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries.

Authors:  Suthira Taychakhoonavudh; Woralak Chumchujan; Raymond Hutubessy; Nathorn Chaiyakunapruk
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

4.  The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Authors:  Cindy Low Gauvreau; Wendy J Ungar; Jillian Clare Köhler; Stanley Zlotkin
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

5.  Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.

Authors:  Don L Douglas; Denise A DeRoeck; Richard T Mahoney; Ole Wichmann
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

6.  Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.

Authors:  Marcello Tirani; Michela Meregaglia; Alessia Melegaro
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  What criteria do decision makers in Thailand use to set priorities for vaccine introduction?

Authors:  Siriporn Pooripussarakul; Arthorn Riewpaiboon; David Bishai; Charung Muangchana; Sripen Tantivess
Journal:  BMC Public Health       Date:  2016-08-02       Impact factor: 3.295

8.  Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Authors:  Bernhard Ultsch; Oliver Damm; Philippe Beutels; Joke Bilcke; Bernd Brüggenjürgen; Andreas Gerber-Grote; Wolfgang Greiner; Germaine Hanquet; Raymond Hutubessy; Mark Jit; Mirjam Knol; Rüdiger von Kries; Alexander Kuhlmann; Daniel Levy-Bruhl; Matthias Perleth; Maarten Postma; Heini Salo; Uwe Siebert; Jürgen Wasem; Ole Wichmann
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 9.  Embedding health policy and systems research into decision-making processes in low- and middle-income countries.

Authors:  Adam D Koon; Krishna D Rao; Nhan T Tran; Abdul Ghaffar
Journal:  Health Res Policy Syst       Date:  2013-08-08

10.  Evaluating the quality and use of economic data in decisions about essential medicines.

Authors:  Corrina Moucheraud; Veronika J Wirtz; Michael R Reich
Journal:  Bull World Health Organ       Date:  2015-08-14       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.